Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v11-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2022-02-09 | 2022-02-08 |
| Drug Identification Number | 01935941 | 01935941 |
| Brand name | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML |
| Common or Proper name | Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 500 mL | Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 500 mL |
| Company Name | B. BRAUN MEDICAL INC | B. BRAUN MEDICAL INC |
| Ingredients | HEPARIN SODIUM CITRIC ACID SODIUM PHOSPHATE DIBASIC DEXTROSE | HEPARIN SODIUM CITRIC ACID SODIUM PHOSPHATE DIBASIC DEXTROSE |
| Strength(s) | 5000UNIT 93MG 410MG 5G | 5000UNIT 93MG 410MG 5G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL | 500 mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2021-12-15 | 2021-12-15 |
| Actual start date | 2021-12-15 | 2021-12-15 |
| Estimated end date | 2022-02-28 | 2022-02-28 |
| Actual end date | 2022-02-08 | 2022-02-08 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |